Landscapes / Companies

Biocad not checked

FollowEvery new trial, moved date and filing, and a Monday email
Furthest along
2 approved
8 in Phase 3
Next date
BCD-217, Phase 3 trial completes
Drugs
14
in active trials · 23 in all
Trials
20 active
54 since 2021

Drugs14

DrugHow it worksPartnerStageNext dateDetails
Monoclonal antibody
Approved in Russia —
Monoclonal antibody
Approved in Russia —
—
Phase 3 Jan 2027Phase 3 trial completes
—
Phase 3 Jul 2028Phase 3 trial completes
—
Phase 3 Dec 2028Phase 3 trial completes
—
Phase 3 —
—
Phase 3 —
—
Phase 3 —
—
Phase 3 —
Monoclonal antibody
Phase 3 —
—
Phase 2 Jan 2027Phase 2 trial completes
—
Phase 2 —
—
Phase 2 —
—
Phase 1 —

About

No active trial
9 other drugs
SEC filings
None: it does not file with the US SEC
Sources
ClinicalTrials.gov updated 18 Nov 2026 Industry-sponsored drug trials since 2021

Follow Biocad

Following is part of Solo: you see every change to Biocad the day it happens.

Solo

$49a month, excl. VAT

  • Follow up to 5 landscapes, companies or drugs
  • Every change, the day it happens
  • A Monday email with the week’s changes
Choose Solo

Free

$0no card

  • One landscape of your own, in full
  • The top 10 of everything else
Sign up free

Have an account? Sign in